Literature DB >> 10558942

Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.

H L Martin1, B A Richardson, P M Nyange, L Lavreys, S L Hillier, B Chohan, K Mandaliya, J O Ndinya-Achola, J Bwayo, J Kreiss.   

Abstract

A prospective cohort study was conducted to examine the relationship between vaginal colonization with lactobacilli, bacterial vaginosis (BV), and acquisition of human immunodeficiency virus type 1 (HIV-1) and sexually transmitted diseases in a population of sex workers in Mombasa, Kenya. In total, 657 HIV-1-seronegative women were enrolled and followed at monthly intervals. At baseline, only 26% of women were colonized with Lactobacillus species. During follow-up, absence of vaginal lactobacilli on culture was associated with an increased risk of acquiring HIV-1 infection (hazard ratio [HR], 2.0; 95% confidence interval [CI], 1.2-3.5) and gonorrhea (HR, 1.7; 95% CI, 1.1-2.6), after controlling for other identified risk factors in separate multivariate models. Presence of abnormal vaginal flora on Gram's stain was associated with increased risk of both HIV-1 acquisition (HR, 1.9; 95% CI, 1.1-3.1) and Trichomonas infection (HR, 1.8; 95% CI, 1.3-2.4). Treatment of BV and promotion of vaginal colonization with lactobacilli should be evaluated as potential interventions to reduce a woman's risk of acquiring HIV-1, gonorrhea, and trichomoniasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558942     DOI: 10.1086/315127

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  323 in total

Review 1.  The microbiota of the vagina and its influence on women's health and disease.

Authors:  David H Martin
Journal:  Am J Med Sci       Date:  2012-01       Impact factor: 2.378

2.  Lower Genital Tract Infections and HIV in Women.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

3.  Recurrent Bacterial Vaginosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

4.  Severity of bacterial vaginosis and the risk of sexually transmitted infection.

Authors:  Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2011-02-27       Impact factor: 8.661

5.  Two novel vaginal microbicides (polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis.

Authors:  Jose A Simoes; Diane M Citron; Alla Aroutcheva; Robert A Anderson; Calvin J Chany; Donald P Waller; Sebastian Faro; Lourens J D Zaneveld
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Acceptability of a self-sampling technique to collect vaginal smears for gram stain diagnosis of bacterial vaginosis.

Authors:  Elizabeth R Boskey; Shelly A Atherly-Trim; Patricia J O'Campo; Donna M Strobino; Dawn P Misra; P Misra
Journal:  Womens Health Issues       Date:  2004 Jan-Feb

Review 7.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

8.  NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW.

Authors:  S E Dover; A A Aroutcheva; S Faro; M L Chikindas
Journal:  Int J Probiotics Prebiotics       Date:  2008

9.  Comparisons of vaginal flora patterns among sexual behaviour groups of women: implications for the pathogenesis of bacterial vaginosis.

Authors:  Kristin M Olson; Louis J Boohaker; Jane R Schwebke; Stella Aslibekyan; Christina A Muzny
Journal:  Sex Health       Date:  2018-02       Impact factor: 2.706

10.  Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study.

Authors:  R Scott McClelland; Jairam R Lingappa; Sujatha Srinivasan; John Kinuthia; Grace C John-Stewart; Walter Jaoko; Barbra A Richardson; Krista Yuhas; Tina L Fiedler; Kishorchandra N Mandaliya; Matthew M Munch; Nelly R Mugo; Craig R Cohen; Jared M Baeten; Connie Celum; Julie Overbaugh; David N Fredricks
Journal:  Lancet Infect Dis       Date:  2018-01-26       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.